BioStem Technologies, Inc.
BSEM
$4.20
-$0.39-8.50%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 58.46M | 210.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 58.46M | 210.39M |
| Cost of Revenue | -- | -- | -- | 10.86M | 10.86M |
| Gross Profit | -- | -- | -- | 47.60M | 199.54M |
| SG&A Expenses | -- | -- | -- | 25.79M | 177.73M |
| Depreciation & Amortization | -- | -- | -- | 213.40K | 217.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 37.85M | 189.78M |
| Operating Income | -- | -- | -- | 20.61M | 20.61M |
| Income Before Tax | -- | -- | -- | 19.45M | 19.45M |
| Income Tax Expenses | -- | -- | -- | 5.83M | 5.83M |
| Earnings from Continuing Operations | -- | -- | -- | 13.62 | 13.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | 13.62M | 13.62M |
| EBIT | -- | -- | -- | 20.61M | 20.61M |
| EBITDA | -- | -- | -- | 20.83M | 20.83M |
| EPS Basic | -- | -- | -- | 0.82 | 0.82 |
| Normalized Basic EPS | -- | -- | -- | 0.77 | 0.77 |
| EPS Diluted | -- | -- | -- | 0.60 | 0.61 |
| Normalized Diluted EPS | -- | -- | -- | 0.58 | 0.59 |
| Average Basic Shares Outstanding | -- | -- | -- | 64.14M | 64.14M |
| Average Diluted Shares Outstanding | -- | -- | -- | 77.51M | 76.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |